101 related articles for article (PubMed ID: 2172271)
1. Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism.
Ulick S; Chan CK; Gill JR; Gutkin M; Letcher L; Mantero F; New MI
J Clin Endocrinol Metab; 1990 Nov; 71(5):1151-7. PubMed ID: 2172271
[TBL] [Abstract][Full Text] [Related]
2. Steroids and hypertension.
Mantero F; Armanini D; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
J Steroid Biochem Mol Biol; 1991; 40(1-3):35-44. PubMed ID: 1958539
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone.
Gomez-Sanchez CE; Gill JR; Ganguly A; Gordon RD
J Clin Endocrinol Metab; 1988 Sep; 67(3):444-8. PubMed ID: 2842358
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic adrenocorticotropin stimulation on the excretion of 18-hydroxycortisol and 18-oxocortisol.
Gomez-Sanchez CE; Clore JN; Estep HL; Watlington CO
J Clin Endocrinol Metab; 1988 Aug; 67(2):322-6. PubMed ID: 2839536
[TBL] [Abstract][Full Text] [Related]
5. Measurement of 4 urinary C-18 oxygenated corticosteroids by stable isotope dilution mass fragmentography.
Ulick S; Chan CK; Wang JZ
J Steroid Biochem Mol Biol; 1991 Jan; 38(1):59-66. PubMed ID: 1997124
[TBL] [Abstract][Full Text] [Related]
6. The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism.
Ulick S; Blumenfeld JD; Atlas SA; Wang JZ; Vaughan ED
J Clin Endocrinol Metab; 1993 Apr; 76(4):873-8. PubMed ID: 8473399
[TBL] [Abstract][Full Text] [Related]
7. Abnormality of aldosterone and cortisol late pathways in glucocorticoid-remediable aldosteronism.
Fallo F; Kuhnle U; Boscaro M; Sonino N
J Clin Endocrinol Metab; 1994 Sep; 79(3):772-4. PubMed ID: 8077359
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid remediable aldosteronism: a case report.
Hsieh CJ; Wang PW; Liu JC; Tung SC; Chien WY; Lu YC; Kuo MC
Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):52-7. PubMed ID: 9178594
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
[TBL] [Abstract][Full Text] [Related]
10. New aspects of mineralocorticoid hypertension.
Mantero F; Armanini D; Biason A; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
Horm Res; 1990; 34(3-4):175-80. PubMed ID: 2151775
[TBL] [Abstract][Full Text] [Related]
11. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.
Geller DS; Zhang J; Wisgerhof MV; Shackleton C; Kashgarian M; Lifton RP
J Clin Endocrinol Metab; 2008 Aug; 93(8):3117-23. PubMed ID: 18505761
[TBL] [Abstract][Full Text] [Related]
12. Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1/CYP11B2 gene.
Fardella CE; Pinto M; Mosso L; Gómez-Sánchez C; Jalil J; Montero J
J Clin Endocrinol Metab; 2001 Oct; 86(10):4805-7. PubMed ID: 11600544
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-remediable aldosteronism.
Halperin F; Dluhy RG
Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-remediable aldosteronism.
Dluhy RG; Lifton RP
Endocrinol Metab Clin North Am; 1994 Jun; 23(2):285-97. PubMed ID: 8070423
[TBL] [Abstract][Full Text] [Related]
16. DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?
Lenders JWM; Williams TA; Reincke M; Gomez-Sanchez CE
Eur J Endocrinol; 2018 Jan; 178(1):R1-R9. PubMed ID: 28904009
[TBL] [Abstract][Full Text] [Related]
17. Two uncommon causes of mineralocorticoid excess. Syndrome of apparent mineralocorticoid excess and glucocorticoid-remediable aldosteronism.
Ulick S
Endocrinol Metab Clin North Am; 1991 Jun; 20(2):269-76. PubMed ID: 1879399
[TBL] [Abstract][Full Text] [Related]
18. A German family with glucocorticoid-remediable aldosteronism.
Vonend O; Altenhenne C; Büchner NJ; Dekomien G; Maser-Gluth C; Weiner SM; Sellin L; Hofebauer S; Epplen JT; Rump LC
Nephrol Dial Transplant; 2007 Apr; 22(4):1123-30. PubMed ID: 17277347
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid-remediable aldosteronism.
McMahon GT; Dluhy RG
Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):682-6. PubMed ID: 15761539
[TBL] [Abstract][Full Text] [Related]
20. Primary aldosteronism: hypertension with a genetic basis.
Gordon RD; Klemm SA; Tunny TJ; Stowasser M
Lancet; 1992 Jul; 340(8812):159-61. PubMed ID: 1352575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
